Role of pilocarpine to prevent radiation induced xerostomia in locally advanced head and neck squamous cell cancer
DOI:
https://doi.org/10.3329/bmjk.v55i1.79724Keywords:
Radiation, Xerostomia, Pilocarpine, Head-Neck CancerAbstract
Background: Radiotherapy of head and neck region generally includes irradiation of the salivary glands. That results in glandular dysfunction which leads to xerostomia. Xerostomia, the subjective sensation of dry mouth which significantly deteriorates the quality of life. Aim and objective: To compare the effects of pilocarpine HCL with basic oral care vs only basic oral care for controlling xerostomia in patients with locally advanced Head and neck squamous Cell Carcinoma patients having definitive concurrent chemoradiotherapy. Material and Method: A prospective observational hospital based study was carried out in the Department of Oncology, Khwaja Yunus Ali Medical College & Hospital from July 2017 to June 2018 on sixty patients of locally advanced HNSCC. All the patients received 66 Gy/33 Fraction/6.5 wks with concurrent weekly cisplatin (40mg/m²). The study group received concomitant Pilocarpine HCL 5 mg three times a day, starting three days prior to start of radiotherapy, continued for 3 months. Patients were evaluated before start of treatment, weekly during radiotherapy and after completion of radiotherapy two weekly over telephone upto 3 months and finally at 6 months using Zimmermen Xerostomia Questionnaire with Visual Analogue Scale and Xerostomia Grading Scale. Result: Overall incidence of xerostomia was significantly lower in pilocarpine group (p<0.05). The average Zimmerman Xerostomia scores of the pilocarpine group as compared to the control group: Dryness of mouth were significantly lower (p<0.05) in each of the assessment after the start of radiotherapy. Significant p value is also found in measurement of comfort status of mouth, sleep impairment, speech impairment and difficulty in eating. Conclusion: Pilocarpine given concomitantly and after radiotherapy has shown to reduce symptoms of xerostomia and lower the degree of post radiation salivary dysfunction than that occurring in the patients who had not received pilocarpine.
Bang Med J Khulna 2022; 55; 13-18